Novel papaverine-based mitochondrial complex i inhibitor smv-32 alleviates tumor hypoxia and radiosensitizes hypoxic tumors

  • No Comments

Novel papaverine-based mitochondrial complex i inhibitor smv-32 alleviates tumor hypoxia and radiosensitizes hypoxic tumors

Novel papaverine-based mitochondrial complex i inhibitor smv-32 alleviates tumor hypoxia and radiosensitizes hypoxic tumors 1241 1755 Metabolism & Cancer

Martin Benej

Download PDF
Email
Leave a Reply
The ATPase inhibitor protein IF1 in cancer cells exposed to anoxia mimicking condition favors survival and proliferation of re-oxygenated cells
Loss of SDHB, but not SDHD, promotes dysregulated oxidative stress and vulnerability to ascorbate
The role of adipocyte G0/G1 Switch Gene 2 (G0S2) in the crosstalk between cancer cells and adipocytes
Mitochondrial complex I null cancer models reveal unspecific antiproliferative effects of complex I inhibitors – Copie
Enter your
text here